¿Cómo se comparó el EPS reciente de EKSO con las expectativas?
¿Cómo fue el desempeño de los ingresos de Ekso Bionics Holdings Inc EKSO en el último trimestre?
¿Cuál es la estimación de ingresos para Ekso Bionics Holdings Inc?
¿Cuál es la puntuación de calidad de ganancias de Ekso Bionics Holdings Inc?
¿Cuándo informa Ekso Bionics Holdings Inc sus ganancias?
¿Cuáles son las ganancias esperadas de Ekso Bionics Holdings Inc?
¿Superó Ekso Bionics Holdings Inc las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$7.92
Precio de apertura
$7.92
Rango del día
$7.6 - $8.39
Rango de 52 semanas
$2.73 - $12.7
Volumen
148.7K
Volumen promedio
2.1M
EPS (TTM)
-5.57
Rendimiento de dividendos
--
Cap. de mercado
$26.9M
¿Qué es EKSO?
Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company is headquartered in San Rafael California, California and currently employs 61 full-time employees. The company went IPO on 2013-04-10. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. The company operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.